These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1622431)

  • 1. Levofloxacin, a new quinolone antibacterial agent. An introductory overview.
    Hayakawa I; Furuhama K; Takayama S; Osada Y
    Arzneimittelforschung; 1992 Mar; 43(3A):363-4. PubMed ID: 1622431
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits.
    Inage F; Kato M; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice.
    Wagai N; Yoshida M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):404-5. PubMed ID: 1622441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levofloxacin].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(4):220-5. PubMed ID: 10420933
    [No Abstract]   [Full Text] [Related]  

  • 7. Twenty-six-week oral toxicity of the new quinolone antibacterial agent levofloxacin in rats and cynomolgus monkeys.
    Kato M; Furuhama K; Woolley AP; Ashby R; Fowler JS; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):367-73. PubMed ID: 1622434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of lomefloxacin, a new difluorinated quinolone, against urinary bacterial isolates: comparison with enoxacin and ofloxacin.
    Azadian BS; Talboys CA; Roberts AP
    J Chemother; 1989 Jul; 1(4 Suppl):176-7. PubMed ID: 16312357
    [No Abstract]   [Full Text] [Related]  

  • 9. Levofloxacin-resistant pneumococcus.
    Klugman KP
    Clin Infect Dis; 2000 Aug; 31(2):626-7. PubMed ID: 10987743
    [No Abstract]   [Full Text] [Related]  

  • 10. [Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
    Budanov SV; Smirnova LB
    Antibiot Khimioter; 2001; 46(5):31-8. PubMed ID: 11558453
    [No Abstract]   [Full Text] [Related]  

  • 11. X-Ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones - racemic ofloxacin and its S-form, levofloxacin.
    Drevensek P; Kosmrlj J; Giester G; Skauge T; Sletten E; Sepcić K; Turel I
    J Inorg Biochem; 2006 Nov; 100(11):1755-63. PubMed ID: 16934331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antibacterial activity of levofloxacin.
    Zhang YY; Wang F; Zhang JD; Zhu DM; Zhou L
    Drugs; 1995; 49 Suppl 2():274-5. PubMed ID: 8549330
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical application of levofloxacin for severe infections.
    Tumminello B; Karaniewsky R; Gutierrez-Solana M
    Chemotherapy; 2006; 52(6):321. PubMed ID: 17047427
    [No Abstract]   [Full Text] [Related]  

  • 14. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ophthalmotoxicity and ototoxicity of the new quinolone antibacterial agent levofloxacin in Long Evans rats.
    Nomura M; Yamada M; Yamamura H; Kajimura T; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):398-403. PubMed ID: 1622440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological testing of non-fluorinated analogues of levofloxacin.
    Gray JL; Almstead JI; Gallagher CP; Hu XE; Kim NK; Taylor CJ; Twinem TL; Wallace CD; Ledoussal B
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2373-5. PubMed ID: 12824037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproductive toxicity of the new quinolone antibacterial agent levofloxacin in rats and rabbits.
    Watanabe T; Fujikawa K; Harada S; Ohura K; Sasaki T; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):374-7. PubMed ID: 1622435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of Maxaquin (lomefloxacin hydrochloride) in the treatment of nonspecific inflammatory diseases and in the prevention of surgical interventions in urology].
    Derevianko II; Lopatkin NA; Khodyreva LA; Kondrat'eva EM
    Urol Nefrol (Mosk); 1998; (5):14-8. PubMed ID: 9820038
    [No Abstract]   [Full Text] [Related]  

  • 19. Preincubation of pneumococci with beta-lactams alone or combined with levofloxacin prevents quinolone-induced resistance without increasing intracellular levels of levofloxacin.
    Cottagnoud P; Johnson M; Cottagnoud M; Piddock L
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3517-9. PubMed ID: 16048972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro antimicrobial activity of a new quinolone, levofloxacin, against atypical mycobacteria].
    Oya S; Takemoto A; Hosaka K; Kudou Y; Arakawa M
    Kekkaku; 1995 Nov; 70(11):615-9. PubMed ID: 8656585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.